Temsirolimus in Treating Patients With Metastatic Neuroendocrine Carcinoma

Clinical trial NCT00093782 · COMPLETED

Trial details

NCT number: NCT00093782
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Gastrointestinal Carcinoid Tumor Pulmonary Carcinoid Tumor Recurrent Gastrointestinal Carcinoid Tumor Recurrent Islet Cell Carcinoma

Start date: 2003-12-01
Primary completion: 2011-04-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.